NASDAQ:BBNX News | QuoteStream

tradingview

Beta Bionics, Inc. Stock 12‑Month Price Target Raised to $20.23, Implies 33% Upside

Explore more price target data and ratings for Beta Bionics, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Beta Bionics, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This informat…

TradingView en_IN 30/7/2026, 03:20 pm GMT+8

StocksUS

BBNX

tradingview

Beta Bionics, Inc. 2Q 2026: Revenue $32M, EPS $(0.53) — 10-Q Summary

Beta Bionics, Inc. reported second-quarter 2026 results with revenue rising to $32M while the company posted a net loss of $23.4M, or diluted EPS of $(0.53), compared with revenue of $23.2M and a net loss of $16.9M, or $(0.39) per share, in the year-ago quarter.Financial HighlightsBusiness Highligh…

TradingView en_IN 30/7/2026, 04:31 am GMT+8

StocksUS